Skip to content
MedsAcross

Medicine

Amnesteem 20 mg capsule

Isotretinoin · Oral · Mylan Pharmaceuticals
Available on requestPrescription onlyUS FDA

Amnesteem 20 mg capsule is a prescription medicine containing Isotretinoin for oral use, marketed by Mylan Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 68° to 77°F (20° to 25°C). Protect from light.

Key facts

Active ingredient (INN)
Isotretinoin
Brand
Amnesteem
Strength
20 mg
Dosage form
Capsule
Route
Oral
Packs
3 blister pack
Marketing authorisation holder
Mylan Pharmaceuticals
Manufacturer
Mylan Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 68° to 77°F (20° to 25°C). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D10AD04 Isotretinoin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
11 November 2002
Identifiers
RxCUI 197843, 197844, 197845 +5DailyMed set ID b2cb63c9-f825-4991-9a2c-6260f1bbcc2cNDC 0378-6612Application ANDA075945

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
3 blister pack in 1 carton / 10 capsule in 1 blister pack0378-6612-93Mylan Pharmaceuticals11 November 2002

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 7 May 1982Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Isotretinoin 20 mg capsule.

Compare all 5

Other strengths and forms of Isotretinoin

Clinical summary

Isotretinoin is a retinoid indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. MedsAcross supplies Isotretinoin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Isotretinoin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Amnesteem 20 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.